Progyny, Inc.

NASDAQ:PGNY

16.61 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 304.087278.078269.94280.891279.373258.394214.321205.371195.004172.217127.553122.284128.651122.133100.30198.92864.60581.02465.12261.19656.16847.19729.18727.79826.15722.258
Cost of Revenue 235.806215.672213.046218.267218.732199.754169.827159.376151.117139.268102.43893.79299.0393.22679.63578.09252.6564.42253.35348.87644.71637.23323.77222.75121.11918.324
Gross Profit 68.28162.40656.89462.62460.64158.6444.49445.99543.88732.94925.11528.49229.62128.90720.66620.83611.95516.60211.76912.3211.4529.9645.4155.0475.0383.934
Gross Profit Ratio 0.2250.2240.2110.2230.2170.2270.2080.2240.2250.1910.1970.2330.230.2370.2060.2110.1850.2050.1810.2010.2040.2110.1860.1820.1930.177
Reseach & Development Expenses 00000000000000000000000000
General & Administrative Expenses 31.17328.42928.18329.52430.07329.34728.20823.57423.55322.99217.60714.98613.93713.08614.72912.1210.1679.4767.376.0685.9814.5083.9753.9863.6243.794
Selling & Marketing Expenses 16.42115.45414.91114.91115.38414.28212.9811.16611.49610.0157.6964.4414.0284.0144.7763.3553.6083.2673.2553.1833.1172.3462.1431.6481.7311.763
SG&A 47.59443.88343.09444.43545.45743.62941.18834.7435.04933.00725.30319.42717.96517.119.50515.47513.77512.74310.6259.2519.0986.8546.1185.6345.3555.779
Other Expenses 3.5643.361.721.7081.2770.4980.2750.0820.025-0.096-0.293-0.0920.0120.0070.0320.0110.0030.16400000000
Operating Expenses 47.59443.88343.09444.43545.45743.62941.18834.7435.04933.00725.30319.42717.96517.119.50515.47513.77512.74310.6259.2519.0986.8546.1185.6345.8145.963
Operating Income 20.68718.52313.818.18915.18415.0113.30611.2558.838-0.058-0.1889.06511.65611.8071.1615.361-1.823.8591.1443.0692.3543.11-0.703-0.587-0.317-1.845
Operating Income Ratio 0.0680.0670.0510.0650.0540.0580.0150.0550.045-0-0.0010.0740.0910.0970.0120.054-0.0280.0480.0180.050.0420.066-0.024-0.021-0.012-0.083
Total Other Income Expenses Net 4.383.9922.4621.7081.2771.320.8350.0820.065-0.084-0.293-0.0920.0120.0070.0320.0110.0030.164-5.757-11.226-0.642-0.551-1.383-0.918-0.803-0.272
Income Before Tax 25.06722.51516.26220.93117.16716.3314.14111.5398.903-0.142-0.3989.11711.9211.7961.1765.355-1.8124.173-4.477-8.1851.5842.521-2.124-1.532-1.12-2.117
Income Before Tax Ratio 0.0820.0810.060.0750.0610.0630.0190.0560.046-0.001-0.0030.0750.0930.0970.0120.054-0.0280.052-0.069-0.1340.0280.053-0.073-0.055-0.043-0.095
Income Tax Expense 8.5825.6172.7925.0332.176-1.3470.733-1.6720.135-5.113-15.478-7.679-6.807-3.37-37.8960.017-0.0050.116-0.0770.0250.0640.589-0.547-0.3950.2890.546
Net Income 16.48516.89813.4715.89814.99117.6783.40813.2118.7684.97115.0816.79618.72715.16639.0725.355-1.8124.057-4.4-8.211.522.521-1.525-1.136-0.831-1.571
Net Income Ratio 0.0540.0610.050.0570.0540.0680.0160.0640.0450.0290.1180.1370.1460.1240.390.054-0.0280.05-0.068-0.1340.0270.053-0.052-0.041-0.032-0.071
EPS 0.180.180.140.170.160.190.0370.140.090.050.170.190.210.170.450.06-0.0210.05-0.069-0.10.0220-0.022-0.016-0.15-0.28
EPS Diluted 0.170.170.130.160.150.180.0340.130.0880.050.150.170.190.150.390.05-0.0210.04-0.069-0.10.0190-0.022-0.014-0.15-0.28
EBITDA 21.44119.23913.818.76815.71115.5523.75211.2559.2240.3060.1289.06511.95212.2291.6255.823-1.364.3797.4414.2953.5454.1711.1680.8050.156-1.397
EBITDA Ratio 0.0710.0690.0510.0670.0560.060.0180.0550.0470.0020.0010.0740.0930.10.0160.059-0.0210.0540.1140.2340.0630.0880.040.0290.006-0.063